Synovics Pharmaceuticals, Inc. (SYVC)

Market Cap	36.00 -100.0%
Revenue (ttm)	19.09M -18.5%
Net Income	-5.04M
EPS	-0.18
Shares Out	36.49M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,400
Average Volume	10,485
Open	0.0000
Previous Close	0.0001
Day's Range	0.0000 - 0.0000
52-Week Range	0.0000 - 0.0001
Beta	170.97
RSI	44.69
Earnings Date	n/a

About Synovics Pharmaceuticals

Synovics Pharmaceuticals, Inc., through its subsidiaries, engages in the development, manufacture, and commercialization of generic over-the-counter (OTC) pharmaceutical products and generic prescription drug products primarily in the United States. The company’s OTC product categories include analgesics, cough, cold, antihistamines, asthma relief, and laxatives. It packages and distributes its products to chain drug stores, wholesalers, and distributors in the United States. The company was formerly known as Bionutrics Inc. and changed its nam...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1983
• Employees: 155
• Stock Exchange: OTCMKTS
• Ticker Symbol: SYVC

Financial Performance

In fiscal year 2008, Synovics Pharmaceuticals's revenue was $25.96 million, an increase of 10.62% compared to the previous year's $23.47 million. Losses were -$4.01 million, -80.79% less than in 2007.